Rankings
▼
Calendar
▼
PMN FY 2025 Earnings Report — ProMIS Neurosciences, Inc. Revenue & Financial Results | Market Cap Arena
ProMIS Neurosciences, Inc.
PMN
FY 2025 Earnings
Reported March 25, 2026
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Metric
FY 2025
Prior Q
FY 2024
QoQ Change
YoY Change
Revenue
$0
—
$0
—
—
Op. Income
-$40M
—
-$17M
—
-138.7%
EPS (Diluted)
$-22.61
—
$2.75
—
-922.2%
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$33.4B
Selling & Marketing
$0
General & Administrative
$6.8B
SG&A Expenses
$6.8B
Other Expenses
-$40.1B
Operating Expenses
$40M
Cost & Expenses
$40M
OPERATING INCOME
-$40M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$448.2K
INCOME BEFORE TAX
-$40M
Income Tax Expense
$0
Net Income from Continuing Ops
-$40M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$39.7B
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$39.7B
D&A
$0
EBIT
-$40M
EBITDA
-$40M
EPS
-$23
EPS Diluted
-$23
marketcaparena.com
← FY 2024
PMN Overview
Q1 2025 →